Penicillin Use in Meningococcal Disease Management: Active Bacterial Core Surveillance Sites, 2009

Amy E Blain; Sema Mandal; Henry Wu; Jessica R MacNeil; Lee H Harrison; Monica M Farley; Ruth Lynfield; Lisa Miller; Megin Nichols; Sue Petit; Arthur Reingold; William Schaffner; Ann Thomas; Shelley M Zansky; Raydel Anderson; Brian H Harcourt; Leonard W Mayer; Thomas A Clark; Amanda C Cohn

doi:10.1093/ofid/ofw152

Penicillin Use in Meningococcal Disease Management: Active Bacterial Core Surveillance Sites, 2009

Open Forum Infect Dis. 2016 Jul 13;3(3):ofw152. doi: 10.1093/ofid/ofw152. eCollection 2016 Sep.

Authors

Amy E Blain¹, Sema Mandal¹, Henry Wu¹, Jessica R MacNeil¹, Lee H Harrison², Monica M Farley³, Ruth Lynfield⁴, Lisa Miller⁵, Megin Nichols⁶, Sue Petit⁷, Arthur Reingold⁸, William Schaffner⁹, Ann Thomas¹⁰, Shelley M Zansky¹¹, Raydel Anderson¹, Brian H Harcourt¹, Leonard W Mayer¹, Thomas A Clark¹, Amanda C Cohn¹

Affiliations

¹ Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases , Centers for Disease Control and Prevention , Atlanta, Georgia.
² Department of International Health , Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland.
³ Department of Medicine , Emory University School of Medicine and the Atlanta VA Medical Center , Georgia.
⁴ Minnesota Department of Health, St. Paul.
⁵ Colorado Department of Public Health and Environment, Denver.
⁶ New Mexico Department of Health, Sante Fe.
⁷ Connecticut Department of Public Health, Hartford.
⁸ School of Public Health , University of California , Berkley.
⁹ Department of Preventive Medicine , Vanderbilt University School of Medicine , Nashville, Tennessee.
¹⁰ Oregon Department of Human Services, Portland.
¹¹ New York State Department of Health, Albany.

Abstract

In 2009, in the Active Bacterial Core surveillance sites, penicillin was not commonly used to treat meningococcal disease. This is likely because of inconsistent availability of antimicrobial susceptibility testing and ease of use of third-generation cephalosporins. Consideration of current practices may inform future meningococcal disease management guidelines.

Keywords: Neisseria meningitidis; antimicrobial resistance; meningitis; meningococcal disease.